Skip to main content
. Author manuscript; available in PMC: 2014 Aug 12.
Published in final edited form as: Ann Pharmacother. 2013 Nov 4;48(1):48–53. doi: 10.1177/1060028013510489

Table 2.

Medication and Procedure Information.

Variable Clopidogrel (n = 39), n (%) or Mean ± SD No Clopidogrel (n = 97), n (%) or Mean ± SD P Value
Preoperative medicationsa
    Aspirin 30 (76.9) 44 (45.4) .001
    GIIb/IIIa inhibitor 3 (7.7) 3 (3.1) .353
    Heparin infusion 1 (2.6) 4 (4.1) 1.000
    Prophylactic unfractionated heparin 0 (0) 3 (3.1) .557
    Prophylactic enoxaparin 0 (0) 1 (1) 1.000
    Warfarin 0 (0) 1 (1) 1.000
Procedure information
    Partial sternotomy performed 4 (10.3) 6 (6.2) .472
    Valve repair or replacement 0 (0) 4 (4.1) .578
    Transmyocardial laser revascularization 1 (2.6) 2 (2.1) 1.000
Number of vessels operated on .115
    1 20 (51.3) 60 (61.9)
    2 19 (48.7) 32 (33)
    3 0 (0) 5 (5.2)
Status of rCABG procedure .087
    Elective 24 (61.5) 75 (77.3)
    Urgentb 15 (38.5) 22 (22.7)

Abbreviations: GIIb/IIIa inhibitor, glycoprotein IIb/IIIa inhibitor; rCABG, robotic-assisted coronary artery bypass graft.

a

Medications are within 24 hours prior to surgery.

b

Defined as urgent if performed during the index admission.